Clinical Trials Logo

Clinical Trial Summary

Triclabendazole is a benzimidazole compound used as a systemic antihelmintic in veterinary practice. Triclabendazole is considered to be a second-line drug for parasites and is used when other preferred agents cannot be used because they are ineffective or because adverse reactions limit their use. Although Triclabendazole is widely used in developing countries for the treatment of parasites it is not approved by the FDA for this treatment in the US. It is currently being distributed in the US through a special arrangement with the FDA and the manufacturer on an individual patient approval basis. This arrangement requires that a single patient Investigational New Drug (IND) be obtained from FDA for each patient requiring Triclabendazole. Upon approval by FDA, the manufacturer (Novartis) will ship the drug directly to the prescribing physician.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01931085
Study type Expanded Access
Source University of Colorado, Denver
Contact
Status No longer available
Phase

See also
  Status Clinical Trial Phase
Active, not recruiting NCT05108675 - Microbiome and Malnutrition in Pregnancy (MMiP)
Terminated NCT00001162 - Parasitic Infections of the Gastrointestinal Tract N/A
Completed NCT01080989 - The Sero-Prevalence and Genetic Study for the Infectious Diseases and Metabolic Syndrome in Solomon Islands N/A
Recruiting NCT06141057 - A Study to Compare Two Dosing Regimens for a New Malaria Vaccine Phase 1
Not yet recruiting NCT06256471 - The Impact of Parasitic Infection on Multiple Sclerosis and Nephrotic Syndrome
Completed NCT04314999 - Frequency of Parasite Infestation in Patients With Chronic Spontaneous Urticaria
Completed NCT04576273 - Enterobius Vermicularis Infestation of the Appendix
Recruiting NCT04992104 - Microbiome and Malnutrition in Pregnancy
Completed NCT04310085 - Study in Blood Stage Malaria Infection After DVI of Cryopreserved P. Falciparum (NF54 Strain) Sporozoites Phase 1
Recruiting NCT05978037 - A Study to Assess the Safety and Effectiveness of Two Experimental Malaria Vaccines Phase 1/Phase 2
Completed NCT05287893 - Pyronaridine in Healthy Adult Participants Infected With Blood Stage Malaria Phase 1
Recruiting NCT00001406 - Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia